The most widely used valuation metric — how to read it, compare it, and avoid its pitfalls.
The Price-to-Earnings (P/E) ratio is the most widely watched valuation metric in finance. It tells you how much investors are paying per dollar of annual earnings.
A P/E of 20 means: for every $1 of earnings this company produces per year, you're paying $20. Another way to think about it: if earnings stayed flat forever, you'd "earn back" your investment in 20 years through profits alone.
There are two common versions, and which you use matters:
Uses the last 12 months of actual reported earnings. Reliable because the numbers are real. Useful for stable, mature companies. Backward-looking, so it misses turning points.
Uses analyst estimates for the next 12 months. More relevant for growing companies or those going through change. But estimates can be wrong — treat it with appropriate scepticism.
Best practice: look at both. If a company has a trailing P/E of 40 but a forward P/E of 22, analysts expect earnings to nearly double — which would explain the apparently high trailing multiple.
There is no universally "good" P/E. Context is everything. Here are the three most useful comparisons:
Is the stock trading at a premium or discount to its own 5-year average P/E? A company that normally trades at 25× now trading at 15× might be undervalued — or signaling problems.
Compare within the same industry. A software company at P/E 40 may be cheap next to peers at 60. A bank at P/E 12 may be expensive if peers trade at 8.
The S&P 500 has historically averaged a P/E of 15–20. Stocks trading well below this without obvious problems may be attractive; those far above it need to justify the premium with growth.
Different industries trade at structurally different multiples. A P/E that's "expensive" in one sector is "cheap" in another:
EPS is an accounting number, not cash. Companies can boost reported earnings through one-time items, aggressive revenue recognition, or share buybacks that reduce share count — inflating EPS without any improvement in the business.
A company losing money has a negative EPS, making P/E undefined. For pre-profit tech or biotech companies, P/E simply doesn't apply — you need Price/Sales or EV/EBITDA.
Two companies with identical P/Es may have very different balance sheets. One might have $10B in cash; the other $10B in debt. The heavily indebted company is riskier and should trade at a lower P/E.
A P/E of 30 could be cheap for a company growing 40% annually or wildly expensive for one growing 3%. Growth rate must always be considered alongside the multiple.
A stock trades at $60 and has earnings per share (EPS) of $3. What is its P/E ratio?
Company A has a P/E of 35 and Company B has a P/E of 12. Which statement is most accurate?
What is the key limitation of using trailing P/E (based on last year's earnings) for valuation?
Use our Stock Analysis and Stock Comparison tools to instantly see P/E ratios, compare them to sector peers, and check historical context.